ImmuPharma plc (LON:IMM – Get Free Report)’s share price traded down 31.4% during mid-day trading on Monday . The stock traded as low as GBX 6.70 and last traded at GBX 6.70. 27,337,178 shares changed hands during trading, an increase of 242% from the average session volume of 7,982,150 shares. The stock had previously closed at GBX 9.76.
ImmuPharma Stock Performance
The stock’s 50 day simple moving average is GBX 11.18 and its 200 day simple moving average is GBX 5.81. The firm has a market cap of £33.68 million, a PE ratio of -7.53 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
See Also
- Five stocks we like better than ImmuPharma
- How to Short Nasdaq: An Easy-to-Follow Guide
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- Why Invest in 5G? How to Invest in 5G Stocks
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- 5 discounted opportunities for dividend growth investors
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
